- Generic name
- Atorvastatin + Ezetimibe
- Strength
- 10 mg + 10 mg
- Dosage form
- Tablet
- Manufactured by
- Delta Pharma Limited
ATV Eze 10 Tablet
About ATV Eze 10 Tablet
The tablet ATV Eze 10 contains Atorvastatin + Ezetimibe and is made by Delta Pharma Limited. The doctor determines if this medicine is suitable based on individual health status and cholesterol levels.
There are 8 brands of Atorvastatin + Ezetimibe listed in Bangladesh.
What is ATV Eze 10 Tablet?
The tablet ATV Eze 10 contains Atorvastatin + Ezetimibe and is made by Delta Pharma Limited. This medicine is used as part of a broader plan that includes diet and other risk factor changes for people at increased risk of heart and blood vessel disease due to high cholesterol. Atorvastatin reduces cholesterol production in the liver and helps clear LDL cholesterol from the blood. The doctor decides the appropriate dose and course for each patient.
Uses of ATV Eze 10
The doctor determines if this medicine is suitable based on individual health status and cholesterol levels. It is prescribed alongside a cholesterol-lowering diet and other lifestyle measures. It is not a standalone treatment; it should be combined with multiple risk factor interventions. Your doctor will decide if it is suitable for you.
How to use ATV Eze 10
The tablet is usually taken by mouth, but the exact schedule depends on the prescription. Swallow the tablet with water. Take ATV Eze 10 exactly as the doctor tells you. Always follow the doctor's instructions and do not change the dose without consulting them. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of ATV Eze 10
Like all medicines, ATV Eze 10 can cause side effects, although not everyone gets them. Some people may experience headache, stomach upset, muscle pain, or tiredness. Tell your doctor promptly if you notice unexplained or persistent muscle pain, tenderness, or weakness, as this can be a sign of a rare but serious muscle problem. Ask your doctor or pharmacist for advice if you are worried about any symptoms.
Safety and precautions
Do not take ATV Eze 10 if you have active liver disease or if you are pregnant or may become pregnant, or if you are breastfeeding. ATV Eze 10 is not for people with active liver disease, unexplained persistent liver enzyme elevations, or hypersensitivity to any ingredient. Women who may become pregnant should use effective contraception and consult their doctor. Ask your doctor before starting any new medicine.
Frequently asked questions
Why is ATV Eze 10 prescribed?
The doctor determines if this medicine is suitable based on individual health status and cholesterol levels. It is prescribed alongside a cholesterol-lowering diet and other lifestyle measures.
How should I take ATV Eze 10?
The tablet is usually taken by mouth, but the exact schedule depends on the prescription. Swallow the tablet with water.
Can ATV Eze 10 cause side effects?
Like all medicines, ATV Eze 10 can cause side effects, although not everyone gets them. Some people may experience headache, stomach upset, muscle pain, or tiredness.
Is ATV Eze 10 safe for everyone?
Do not take ATV Eze 10 if you have active liver disease or if you are pregnant or may become pregnant, or if you are breastfeeding. ATV Eze 10 is not for people with active liver disease, unexplained persistent liver enzyme elevations, or hypersensitivity to any ingredient.
Indications
Primary Hyperlipidemia: This tablet is indicated for the reduction of elevated total cholesterol (total-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and non-high-density lipoprotein cholesterol (non-HDL-C), and to increase high-density lipoprotein cholesterol (HDL-C) in patients with primary (heterozygous familial and non-familial) hyperlipidemia or mixed hyperlipidemia.
Homozygous Familial Hypercholesterolemia (HoFH): This tablet is indicated for the reduction of elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to other lipid lowering treatments (e.g., LDL apheresis) or if such treatments are unavailable.
Pharmacology
Ezetimibe: Ezetimibe reduces blood cholesterol by inhibiting the absorption of cholesterol by the small intestine. The molecular target of ezetimibe has been shown to be the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is involved in the intestinal uptake of cholesterol and phytosterols. In a 2-week clinical study in 18 hypercholesterolemic patients, ezetimibe inhibited intestinal cholesterol absorption by 54%, compared with placebo. Ezetimibe had no clinically meaningful effect on the plasma concentrations of the fat-soluble vitamins A, D, and E and did not impair adrenocortical steroid hormone production. Ezetimibe does not inhibit cholesterol synthesis in the liver or increase bile acid excretion. Ezetimibe localizes at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver. This causes a reduction of hepatic cholesterol stores and an increase in clearance of cholesterol from the blood; this distinct mechanism is complementary to that of statins.
Dosage & Administration
Interaction
- Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir), gemfibrozil: Avoid this tablet
- HIV protease inhibitor (lopinavir plus ritonavir): Use with caution and lowest dose necessary.
- Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir): Do not exceed 10/20 mg this tablet daily.
- HIV protease inhibitor (nelfinavir), hepatitis C protease inhibitor (boceprevir): Do not exceed 10/40 mg this tablet daily.
- Other lipid-lowering medications: Use with fenofibrates or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. Caution should be used when prescribing with this tablet.
- Fenofibrates: Combination increases exposure of ezetimibe. If cholelithiasis is suspected in a patient receiving ezetimibe and a fenofibrate, gallbladder studies are indicated and alternative lipid- lowering therapy should be considered.
- Cholestyramine: Combination decreases exposure of ezetimibe.
- Digoxin: Patients should be monitored appropriately.
- Oral contraceptives: Values for norethindrone and ethinyl estradiol may be increased.
- Rifampin should be simultaneously coadministered with this tablet.
Contraindications
- Active liver disease or unexplained persistent elevations of hepatic transaminase levels.
- Hypersensitivity to any component of this tablet.
- Women who are pregnant or may become pregnant.
- Nursing mothers.
Pregnancy & Lactation
Precautions & Warnings
Skeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with higher doses and concomitant use of certain CYP3A4 inhibitors, fibric acid derivatives, and cyclosporine. Predisposing factors include advanced age (>65), uncontrolled hypothyroidism, and renal impairment. Rare cases of rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported.
Liver enzyme abnormalities: Persistent elevations in hepatic transaminase can occur. Check liver enzyme tests before initiating therapy and as clinically indicated thereafter.
Storage Conditions
Alternative brands of Atorvastatin + Ezetimibe
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.